LEADER 03851nam  22005775  450 
001 9910407712103321
005 20200702205906.0
010   $a981-15-2724-5
024 7 $a10.1007/978-981-15-2724-1
035   $a(CKB)5310000000016672
035   $a(MiAaPQ)EBC6229430
035   $a(DE-He213)978-981-15-2724-1
035   $a(EXLCZ)995310000000016672
100   $a20200615d2020      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aGlobal Pharmaceutical Policy /$fedited by Zaheer-Ud-Din Babar
205   $a1st ed. 2020.
210  1$aSingapore :$cSpringer Singapore :$cImprint: Palgrave Macmillan,$d2020.
215   $a1 online resource (376 pages)
311   $a981-15-2723-7 
327   $a1 Medicines Safety in the Gloablized Context -- 2 Managing the Pharmaceutical Supply Chain ? To Sustainability and Beyond -- 3 Generic Medicines and Biosimilars: Impact on Global Pharmaceutical Policy -- 4 Global Access to Cancer Medicines -- 5 Medicines Pricing: Limitations of Existing Policies and New Models -- 6 Pharmacy Practice and Policy Research in Pakistan: A Review of Literature Between 2014-2019 -- 7 Promoting Access to Cancer Medicines in Mexico: Seguro Popular Key Policy Components -- 8 Access to Medicines: Case Studies from Lmics (Russia and Kyrgyzstan) -- 9 Access and Use of Medicines in Ukraine -- 10 Public Participation in Access to Medicines -- 11 Pharmaceutical Policy and Practice: A Review of Synthesis and Studies in China -- 12 Access to Vaccines and Immunization Programme -- 13. Global Antibiotics Use and Resistance -- 14 Medicines Access, Use and Pharmaceutical Health System Issues: Reflections, Thoughts and Points to Consider.
330   $aMedicines are vital in improving patient health outcomes and pharmaceutical policy is a fundamental component of any health system. However, the global pharmaceutical policy is ever-evolving and data and quality ?research-based information? in this field are scarce. This book fills this gap and provides up-to-date empirical information and evidence-based synthesis. It focuses on pertinent key issues in global pharmaceutical policy including medicines safety, generic medicines, pharmaceutical supply chain, medicines financing, access and affordability of medicines, rational use of medicines, pharmacy health services research and access to vaccines and biological products. Featuring policy case studies from varied countries such as Mexico, Russia, China, Kyrgyzstan, and Pakistan, this book comprises a valuable and comprehensive resource for students, funders, policymakers, academics, and researchers interested in this field.
606   $aSociology
606   $aSocial medicine
606   $aPharmacology
606   $aMedical policy
606   $aSociology, general$3https://scigraph.springernature.com/ontologies/product-market-codes/X22000
606   $aMedical Sociology$3https://scigraph.springernature.com/ontologies/product-market-codes/X22150
606   $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007
606   $aHealth Policy$3https://scigraph.springernature.com/ontologies/product-market-codes/H27040
615  0$aSociology.
615  0$aSocial medicine.
615  0$aPharmacology.
615  0$aMedical policy.
615 14$aSociology, general.
615 24$aMedical Sociology.
615 24$aPharmacology/Toxicology.
615 24$aHealth Policy.
676   $a362.1782
702   $aBabar$b Zaheer-Ud-Din$4edt$4http://id.loc.gov/vocabulary/relators/edt
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910407712103321
996   $aGlobal Pharmaceutical Policy$92513657
997   $aUNINA